d-Cycloserine for PTSD Proves Underwhelming

The field is still very new, and gaps in knowledge are numerous, both at the basic science and clinical level, said Dr. Marmar, urging patience.

“The fact that DCS has been shown to accelerate or improve the effectiveness of behavioral treatments for other disorders, like phobia, social anxiety, and some others suggests we should continue to work on this drug with PTSD – and try to refine it and try to determine the optimal parameters in dosing and scheduling.”